Ligand Pharmaceuticals | LGND - 市值

股票价格

231.27

每天变化

2.79 1.22%

每月一次

13.06%

每年

114.00%

Q2 预测

226.32

金融业

USD

USD 1.56B

现金及等价物

USD 174.93M

USD 11.9M

USD 832.27M

USD 37.45M

USD 451M

USD 158.89M

USD 150.32M

68

EPS每股收益

USD 2.02

股本和储备

USD 1.02B

USD 155.28M

债务利息支出

USD 910K

USD 3.87M

USD 445.49M

USD 4.05B

USD 117.27M

USD 8.29M

USD 158.89M

普通股股本

USD 19.66M

60.65

USD 141.14M

USD 59.66M

销售和管理费用

USD 28.45M

USD 9.13M

贸易债权人

USD 3.24M

应收帐款人

USD 58.1M

	市值	更改		日
Agenus	USD 107M		16M	2025-12
Amgen	USD 176.25B		24.32B	2025-12
Anika Therapeutics	USD 139M		3M	2025-12
Arrowhead Research	USD 9.02B		4.25B	2025-12
Baxter International	USD 9.82B		1.87B	2025-12
Bristol-Myers Squibb	USD 109.81B		18.01B	2025-12
Eli Lilly	USD 1.02T		293.84B	2025-12
Enanta Pharmaceuticals	USD 122M		98M	2024-12
Enviri Corporation	USD 1.45B		423M	2025-12
Gilead Sciences	USD 166.62B		14.34B	2026-04
GlaxoSmithKline	GBP 74.36B		10.31B	2025-12
Glaxosmithkline	GBP 99.93B		13.05B	2025-12
Heron Therapeutics	USD 238M		7M	2025-12
Insmed	USD 37.12B		6.68B	2025-12
Ionis Pharmaceuticals	USD 12.81B		2.39B	2025-12
Karyopharm Therapeutics	USD 652M		517M	2026-04
MacroGenics	USD 102M		4M	2025-12
Merck	USD 261.26B		51.62B	2025-12
Pacira	USD 1.06B		94M	2025-12
Pfizer	USD 141.57B		6.48B	2025-12
Veracyte	USD 3.33B		627M	2025-12